Photocure Asa Stock Today
| PHCUF Stock | USD 5.60 1.12 25.00% |
Performance8 of 100
| Odds Of DistressLess than 9
|
Photocure ASA is trading at 5.60 as of the 27th of December 2024. This is a 25.00% up since the beginning of the trading day. The stock's lowest day price was 5.6. Photocure ASA has less than a 9 % chance of experiencing financial distress in the next few years but had a somewhat ok performance during the last 90 days. The performance scores are derived for the period starting the 7th of January 2023 and ending today, the 27th of December 2024. Click here to learn more.
Photocure ASA, a specialty pharmaceutical company, engages in the research, development, production, distribution, marketing, and sale of pharmaceutical products in Nordic countries, Germany, France, Austria, the United Kingdom, the Netherlands, Italy, other European Countries, and the United States. The company has 27.11 M outstanding shares. More on Photocure ASA
Moving against Photocure Pink Sheet
Photocure Pink Sheet Highlights
| President CEO | Daniel Schneider |
| Business Concentration | Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors) |
Photocure ASA [PHCUF] is a Pink Sheet which is traded between brokers as part of OTC trading. The company currently falls under 'Small-Cap' category with a current market capitalization of 300.81 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Photocure ASA's market, we take the total number of its shares issued and multiply it by Photocure ASA's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Photocure ASA classifies itself under Healthcare sector and is part of Drug Manufacturers—Specialty & Generic industry. The entity has 27.11 M outstanding shares.
Photocure ASA has accumulated about 283.87 M in cash with 23.89 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 10.47, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Photocure ASA Probability Of Bankruptcy
Ownership AllocationPhotocure ASA owns a total of 27.11 Million outstanding shares. 30% of Photocure ASA outstanding shares are owned by third-party entities. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Photocure Ownership Details
Photocure ASA Risk Profiles
| Mean Deviation | 1.22 | |||
| Standard Deviation | 3.88 | |||
| Variance | 15.02 | |||
| Risk Adjusted Performance | 0.0909 |
Photocure Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Photocure ASA without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Money Flow Index Now
Money Flow IndexDetermine momentum by analyzing Money Flow Index and other technical indicators |
| All Next | Launch Module |
Photocure ASA Corporate Management
| Tolv Hillestad | Group Controller | Profile | |
| Erik Dahl | Chief Officer | Profile | |
| Patricia Kelly | VP HR | Profile | |
| David Moskowitz | Head Relations | Profile | |
| Anders Neijber | Clinical Affairs | Profile | |
| Kari MD | Head Devel | Profile |
Other Information on Investing in Photocure Pink Sheet
Photocure ASA financial ratios help investors to determine whether Photocure Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Photocure with respect to the benefits of owning Photocure ASA security.